Cheongju-si, South Korea

In Duk Jung

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Cheongju-si, KR (2020)
  • Seoul, KR (2020)

Company Filing History:


Years Active: 2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: In Duk Jung: Innovator in Antibacterial Compositions

Introduction

In Duk Jung is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of antibacterial compositions, particularly in combating resistant bacteria. With a total of 3 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents is an antibacterial composition for combating carbapenem-resistant gram-negative bacteria, which includes adenylate kinase (ADK) protein as the active ingredient. This composition demonstrates excellent antimicrobial activity against resistant bacteria, making it a valuable asset in various fields. Another significant patent involves compositions for preventing or treating sepsis or septic shock, also utilizing ADK protein. This invention has shown promising results in enhancing viability in sepsis animal models and suppressing inflammatory responses.

Career Highlights

In Duk Jung is affiliated with the Konkuk University Glocal Industry-Academic Collaboration Foundation, where he continues to innovate and develop his research. His work is crucial in addressing the challenges posed by antibiotic-resistant infections.

Collaborations

He collaborates with notable colleagues, including Yeong Min Park and Jung Hee Park, contributing to a dynamic research environment.

Conclusion

In Duk Jung's innovative work in antibacterial compositions highlights the importance of research in combating resistant bacteria and improving treatment options. His contributions are essential in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…